Making the Case for Palliative Care in Critical Care

Critical Care Nursing Clinics of North America
Tonja M Hartjes

Abstract

The United States has a changing populace with an increasing number of vulnerable, diverse, and older adults. Of people aged 65 and older, nearly two-thirds suffer from serious comorbidities. Costs associated with chronic illness increase with age and number of conditions. More than 25% of older adults do not have advanced care planning. The current model of health care cannot meet these needs. The initiation of palliative care in the ICU will capture many patients who meet the criteria for palliative care and improve their QOL by management their end-of-life symptoms and reduce unnecessary utilization of health care resources.

References

Apr 9, 2008·American Journal of Respiratory and Critical Care Medicine·Paul N LankenUNKNOWN ATS End-of-Life Care Task Force
Oct 15, 2009·Palliative Medicine·Sean O'MahonyVladimir Kvetan
Jun 22, 2010·Critical Care Medicine·Judith E NelsonUNKNOWN Improve Palliative Care in the Intensive Care Unit Project
Feb 9, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J SmithJamie H Von Roenn
Nov 13, 2012·Nursing Outlook·Noreen M AzizJ Randall Curtis
Sep 3, 2013·Current Opinion in Critical Care·Rebecca A Aslakson, John F P Bridges

❮ Previous
Next ❯

Citations

Dec 19, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Amanda BriseboisPuneeta Tandon
Nov 15, 2018·Nursing in Critical Care·Freda DeKeyser Ganz, Batel Sapir

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Nursing
Denice K Sheehan, Victoria Schirm
British Journal of Community Nursing
Brian Nyatanga
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses
Mariam E Wisnewski, M Jean Reed
© 2021 Meta ULC. All rights reserved